{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:25:33Z","timestamp":1790702733274,"version":"4.1.0"},"reference-count":26,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Oradea","award":["187"],"award-info":[{"award-number":["187"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: A large number of substance use disorders are increasingly associated with complex clinical presentations and unknown mental and medical risks, presenting a growing challenge for mental health worldwide. Research exploring the interplay between substance use and psychiatric disorders remains limited in Eastern Europe. Objectives: We investigated the demographic and clinical features of 203 patients admitted to a major Romanian psychiatric hospital, aiming to clarify the patterns of dual diagnosis and symptomatology within this vulnerable population. Results: Cannabis, novel psychoactive substances and unknown substances were the most commonly used drugs. Psychiatric comorbidity was rather the rule than the exception within our group. Cluster analysis revealed three distinct symptom profiles: manic\/psychotic, negative affective and disorganized. While individual drug type did not independently predict symptom severity or readmission risk, a significant interaction effect between drug use and psychiatric comorbidity influenced symptom cluster membership. Conclusions: These findings highlight the complexity and heterogeneity of dual diagnoses and underline the importance of an integrated, multidisciplinary approach in addiction medicine.<\/jats:p>","DOI":"10.3390\/healthcare13192543","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:41:02Z","timestamp":1760002862000},"page":"2543","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patterns of Psychiatric Comorbidity Among Drug Users: A Prospective Observational Study in a Romanian Psychiatric Hospital"],"prefix":"10.3390","volume":"13","author":[{"given":"Andreea Atena","family":"Zaha","sequence":"first","affiliation":[{"name":"Doctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia Lucia","family":"Com\u0219a","sequence":"additional","affiliation":[{"name":"County Emergency Hospital, 400347 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4021-4989","authenticated-orcid":false,"given":"Dana Carmen","family":"Zaha","sequence":"additional","affiliation":[{"name":"Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410068 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5071-9601","authenticated-orcid":false,"given":"Cosmin Mihai","family":"Vesa","sequence":"additional","affiliation":[{"name":"Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410068 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/psychoactives3020018","article-title":"New Psychoactive Substances: Health and Legal Challenges","volume":"3","author":"Santos","year":"2024","journal-title":"Psychoactives"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eclinm.2019.09.014","article-title":"Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis","volume":"16","author":"McKetin","year":"2019","journal-title":"eClinicalMedicine"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Guerin, A.A., Bridson, T., Plapp, H.M., and Bedi, G. (2023). A systematic review and meta-analysis of health, functional, and cognitive outcomes in young people who use methamphetamine. Neurosci. Biobehav. Rev., 153.","DOI":"10.1016\/j.neubiorev.2023.105380"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-022-01389-z","article-title":"Towards an understanding of psychedelic-induced neuroplasticity","volume":"48","author":"Calder","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"ref_5","first-page":"1223","article-title":"Reconsidering evidence for psychedelic-induced psychosis: An overview of reviews, a systematic review, and meta-analysis of human studies","volume":"30","author":"Sulstarova","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.34172\/ahj.2023.1411","article-title":"New Psychoactive Substances: A Potential Threat to Developing Countries","volume":"15","author":"Hasan","year":"2023","journal-title":"Addict. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100060","DOI":"10.1016\/j.addicn.2022.100060","article-title":"The novel psychoactive substances epidemic: A scientometric perspective","volume":"5","author":"Neoh","year":"2023","journal-title":"Addict. Neurosci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Daziani, G., Lo Faro, A.F., Montana, V., Goteri, G., Pesaresi, M., Bambagiotti, G., Montanari, E., Giorgetti, R., and Montana, A. (2023). Synthetic Cathinones and Neurotoxicity Risks: A Systematic Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076230"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/da.22771","article-title":"Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature","volume":"35","author":"Turner","year":"2018","journal-title":"Depress. Anxiety"},{"key":"ref_10","unstructured":"EUDA (2025, March 13). New Psychoactive Substances\u2014The Current Situation in Europe (European Drug Report 2024). Available online: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2024\/new-psychoactive-substances_en."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S575","DOI":"10.1192\/j.eurpsy.2021.1535","article-title":"Comparative study of psychoactive substance use pattern in Romania and Hungary","volume":"64","author":"Costescu","year":"2021","journal-title":"Eur. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"114659","DOI":"10.1016\/j.psychres.2022.114659","article-title":"Utility and validity of the Brief Psychiatric Rating Scale (BPRS) as a transdiagnostic scale","volume":"314","author":"Hofmann","year":"2022","journal-title":"Psychiatry Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.chc.2016.06.004","article-title":"Substance Use Among College Students","volume":"25","author":"Skidmore","year":"2016","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/dar.13064","article-title":"Loneliness among people with substance use problems: A narrative systematic review","volume":"39","author":"Ingram","year":"2020","journal-title":"Drug Alcohol Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00737-022-01247-3","article-title":"Sex and gender differences in symptoms of early psychosis: A systematic review and meta-analysis","volume":"25","author":"Carter","year":"2022","journal-title":"Arch. Women\u2019s Ment. Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.33411\/IJIST\/2022040609","article-title":"Psycho-Social and Morbidity of Substance Use Disorder in Women","volume":"4","author":"Iftikhar","year":"2022","journal-title":"Int. J. Innov. Sci. Technol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.v67n0211","article-title":"Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Conway","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jad.2014.09.016","article-title":"Cannabis use and mania symptoms: A systematic review and meta-analysis","volume":"171","author":"Gibbs","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s11469-022-00821-1","article-title":"Psychiatric Comorbidities of Substance Use Disorders: Does Dual Diagnosis Predict Inpatient Detoxification Treatment Outcomes?","volume":"21","author":"Davis","year":"2023","journal-title":"Int. J. Ment. Health Addict."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1176\/appi.ajp.161.1.139","article-title":"Comparisons of patients with comorbid psychiatric and substance use disorders: Implications for treatment and service delivery","volume":"161","author":"Havassy","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Andersson, H.W., Mosti, M.P., and Nordfjaern, T. (2023). Inpatients in substance use treatment with co-occurring psychiatric disorders: A prospective cohort study of characteristics and relapse predictors. BMC Psychiatry, 23.","DOI":"10.1186\/s12888-023-04632-z"},{"key":"ref_22","unstructured":"Zaha, V.-G., and Dumitriu, A. (2025, August 12). Public Anti-Drug Policies in Romania\u2014Between Criminal Justice and Public Health. Analysis, Friedrich Ebert Stiftung, 2023. Available online: https:\/\/library.fes.de\/pdf-files\/bueros\/bukarest\/20633.pdf."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Marquez-Arrico, J.E., Navarro, J.F., and Adan, A. (2020). Health-Related Quality of Life in Male Patients under Treatment for Substance Use Disorders with and without Major Depressive Disorder: Influence in Clinical Course at One-Year Follow-Up. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103110"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Adan, A., and Torrens, M. (2021). Special Issue: Diagnosis and Management of Addiction and Other Mental Disorders (Dual Disorders). J. Clin. Med., 10.","DOI":"10.3390\/jcm10061307"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2975\/29.2005.114.121","article-title":"Predictors of psychiatric hospitalization for adults with co-occurring substance and mental disorders as compared to adults with mental illness only","volume":"29","author":"Min","year":"2005","journal-title":"Psychiatr. Rehabil. J."},{"key":"ref_26","unstructured":"(2025, May 15). European Drug Report 2024: Trends and Developments. Available online: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2024_en."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/13\/19\/2543\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:50:52Z","timestamp":1760035852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/13\/19\/2543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":26,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["healthcare13192543"],"URL":"https:\/\/doi.org\/10.3390\/healthcare13192543","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}